1. Home
  2. SLAB vs SYRE Comparison

SLAB vs SYRE Comparison

Compare SLAB & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silicon Laboratories Inc.

SLAB

Silicon Laboratories Inc.

HOLD

Current Price

$217.47

Market Cap

6.7B

Sector

Technology

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$73.34

Market Cap

6.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLAB
SYRE
Founded
1996
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.7B
6.5B
IPO Year
2000
2015

Fundamental Metrics

Financial Performance
Metric
SLAB
SYRE
Price
$217.47
$73.34
Analyst Decision
Hold
Strong Buy
Analyst Count
11
12
Target Price
$163.13
$85.08
AVG Volume (30 Days)
335.3K
848.2K
Earning Date
05-12-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
66.61
N/A
EPS
N/A
N/A
Revenue
$491,625,000.00
N/A
Revenue This Year
$20.49
N/A
Revenue Next Year
$16.65
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$115.51
$13.93
52 Week High
$219.33
$78.80

Technical Indicators

Market Signals
Indicator
SLAB
SYRE
Relative Strength Index (RSI) 61.06 55.17
Support Level $215.02 $65.93
Resistance Level $218.68 $76.16
Average True Range (ATR) 1.12 3.87
MACD -0.24 -0.82
Stochastic Oscillator 66.82 56.86

Price Performance

Historical Comparison
SLAB
SYRE

About SLAB Silicon Laboratories Inc.

Silicon Laboratories Inc Inc is a provider of secure, intelligent wireless technology for a more connected world. The company's integrated hardware and software platform, intuitive development tools, industry ecosystem, and robust support help customers build industrial, commercial, home, and life applications. Company make it easy for developers to solve complex wireless challenges throughout the product lifecycle and get to market quickly with solutions that transform industries, grow economies, and improve lives. Company operates in USA, China, Taiwan and Rest of World, with maximum revenue from rest of the world.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: